DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype
Cell Reports · 2023-08 · 42 (8) · 112927
DOI: 10.1016/j.celrep.2023.112927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-08. Verfasst von Estefania Cuesta-Borràs und 18 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cells and Cancer Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Colorectal Neoplasms, Drug Resistance, Neoplasm, Cell Cycle. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union's Research and Innovation, Innovative Medicines Initiative, European Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stem Cells and Cancer Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.
- Stem Cells and Cancer Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain; University of Barcelona, Barcelona, Spain.
- Stem Cells and Cancer Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain; CIBERONC, 08029 Madrid, Spain.
- Gastrointestinal and Endocrine Tumors Group, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, S…
- Nanomaterials and Nanotechnology Research Center (CINN), Spanish National Research Council (CSIC), Health Research Institute of the Principality of Asturias (ISPA), Spanish Biomedical Research Network in Rare Diseases (…
- CIBERONC, 08029 Madrid, Spain; Gastrointestinal and Endocrine Tumors Group, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barc…
Förderung
- European Union's Research and Innovation
- Innovative Medicines Initiative
- European Commission
- Fundación Científica de la Asociación Española Contra el Cáncer
- Instituto de Salud Carlos III
- Fundacion La Caixa
- Agencia Estatal de Investigación
Zitieren
APA
Cuesta-Borràs, E., Salvans, C., Arqués, O., Chicote, I., Ramírez, L., Cabellos, L., Martínez-Quintanilla, J., Mur-Espinosa, A., García-Álvarez, A., Hernando, J., Tejedor, J. R., Mirallas, O., Élez, E., Fraga, M. F., Tabernero, J., Nuciforo, P., Capdevila, J., Palmer, H. G., & Puig, I. (2023). DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype. Cell Reports, 42(8), 112927. https://doi.org/10.1016/j.celrep.2023.112927
Vancouver
Cuesta-Borràs E, Salvans C, Arqués O, Chicote I, Ramírez L, Cabellos L, et al. DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype. Cell Reports. 2023;42(8):112927. doi:10.1016/j.celrep.2023.112927
BibTeX
@article{CuestaBorrs2023,
author = {Cuesta-Borràs, Estefania and Salvans, Cándida and Arqués, Oriol and Chicote, Irene and Ramírez, Lorena and Cabellos, Laia and Martínez-Quintanilla, Jordi and Mur-Espinosa, Alex and García-Álvarez, Alejandro and Hernando, Jorge and Tejedor, Juan Ramón and Mirallas, Oriol and Élez, Elena and Fraga, Mario F and Tabernero, Josep and Nuciforo, Paolo and Capdevila, Jaume and Palmer, Héctor G and Puig, Isabel},
title = {DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {8},
pages = {112927},
doi = {10.1016/j.celrep.2023.112927}
}
EUVIMED